Items where Author is "Morel, C. M."

Item Type No Grouping

Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of MRSA infection: a health-care system perspective. von Dach, E. and Morel, C. M. and Murthy, A. and Pagani, L. and Macedo-Vinas, M. and Olearo, F. and Harbarth, S.

Economic and systems-related bottlenecks in the market for rapid, point-of-care diagnostics for bacterial infection. Morel, C. M. and McClure, L. and Edwards, S. and McGrath, S.